Caricamento...
Going Back to Class I: MHC and Immunotherapies for Childhood Cancer
After decades of unfulfilled promise, immunotherapies for cancer have finally reached a tipping point, with several FDA approved products now on the market and many more showing promise in both adult and pediatric clinical trials. Tumor cell expression of MHC Class I has emerged as a potential deter...
Salvato in:
| Pubblicato in: | Pediatr Blood Cancer |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4339346/ https://ncbi.nlm.nih.gov/pubmed/25524394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25359 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|